Raziel Therapeutics Ltd.

9 clinical trials · Sponsor

Record	Firm	Date
An Open-label Study That Will Test a Second Treatment Session of RZL-012. (NCT05763160)	Raziel Therapeutics Ltd.	2023-05-29
Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events (NCT05476679)	Raziel Therapeutics Ltd.	2022-09-25
An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects. (NCT05466448)	Raziel Therapeutics Ltd.	2022-07-29
Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks (NCT05445557)	Raziel Therapeutics Ltd.	2022-03-10
Efficacy and Safety of RZL-012 on Submental Fat Reduction (NCT04867434)	Raziel Therapeutics Ltd.	2021-06-15
RZL-012 for Dercum's Disease Lipomas (NCT04229030)	Raziel Therapeutics Ltd.	2020-07-30
A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers. (NCT04086823)	Raziel Therapeutics Ltd.	2020-02-25
Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease (NCT03492840)	Raziel Therapeutics Ltd.	2018-06-28

Every clearance here is in the API, with alerts when new ones post.